Haojing Rong,Andrea Iskenderian,Angela W. Norton,Chuan Shen,Clark Pan
申请号：
US15977635
公开号：
US20180362604A1
申请日:
2018.05.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of a recombinant follistatin fusion protein such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.
